<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD03030000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P42768</UniProt_ID>
  <Seq_Length>502</Seq_Length>
  <Molecule_Weight>52913</Molecule_Weight>
  <KEGG_ID>hsa:7454</KEGG_ID>
  <Orthology_ID>K05747</Orthology_ID>
  <EBI_ID>EBI-346375</EBI_ID>
  <Function_Summary>Effector protein for Rho-type GTPases. Regulates actin filament reorganization via its interaction with the Arp2/3 complex. Important for efficient actin polymerization. Possible regulator of lymphocyte and platelet function. Mediates actin filament reorganization and the formation of actin pedestals upon infection by pathogenic bacteria.</Function_Summary>
  <Pfam_ID>PF00786:PBD@@PF00568:WH1@@PF02205:WH2</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>5</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Thrombocytopenia 1 (X-linked)</Alias>
      <Alias>WASp</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Modulates the rate of GTP hydrolysis by a small monomeric GTPase.</Detail>
      <Keyword>Small GTPase regulator activity</Keyword>
      <Ontology_ID>GO:0005083</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an identical protein or proteins.</Detail>
      <Keyword>Identical protein binding</Keyword>
      <Ontology_ID>GO:0042802</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with monomeric or multimeric forms of actin, including actin filaments.</Detail>
      <Keyword>Actin binding</Keyword>
      <Ontology_ID>GO:0003779</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>58</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>187</Position>
      <Original>Gly</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>86</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>86</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>31</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>134</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>27</Position>
      <Original>Leu</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>75</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>477</Position>
      <Original>Arg</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>52</Position>
      <Original>Gln</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>48</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>481</Position>
      <Original>Ile</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>236</Position>
      <Original>Ala</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>58</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>56</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>476</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>133</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>86</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>83</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>97</Position>
      <Original>Trp</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>73</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>43</Position>
      <Original>Cys</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>45</Position>
      <Original>Thr</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>270</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>89</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>131</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>82</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>84</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>70</Position>
      <Original>Gly</Original>
      <Variation>Trp</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.</Detail>
      <Keyword>Immune response</Keyword>
      <Ontology_ID>GO:0006955</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.</Detail>
      <Keyword>T cell receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0050852</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack.</Detail>
      <Keyword>Defense response</Keyword>
      <Ontology_ID>GO:0006952</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process whose specific outcome is the progression of the epidermis over time, from its formation to the mature structure. The epidermis is the outer epithelial layer of a plant or animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species.</Detail>
      <Keyword>Epidermis development</Keyword>
      <Ontology_ID>GO:0008544</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.</Detail>
      <Keyword>Blood coagulation</Keyword>
      <Ontology_ID>GO:0007596</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>484</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>291</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>483</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MSGGPMGGRPGGRGAPAVQQNIPSTLLQDHENQRLFEMLGRKCLTLATAVVQLYLALPPGAEHWTKEHCGAVCFVKDNPQKSYFIRLYGLQAGRLLWEQELYSQLVYSTPTPFFHTFAGDDCQAGLNFADEDEAQAFRALVQEKIQKRNQRQSGDRRQLPPPPTPANEERRGGLPPLPLHPGGDQGGPPVGPLSLGLATVDIQNPDITSSRYRGLPAPGPSPADKKRSGKKKISKADIGAPSGFKHVSHVGWDPQNGFDVNNLDPDLRSLFSRAGISEAQLTDAETSKLIYDFIEDQGGLEAVRQEMRRQEPLPPPPPPSRGGNQLPRPPIVGGNKGRSGPLPPVPLGIAPPPPTPRGPPPPGRGGPPPPPPPATGRSGPLPPPPPGAGGPPMPPPPPPPPPPPSSGNGPAPPPLPPALVPAGGLAPGGGRGALLDQIRQGIQLNKTPGAPESSALQPPPQSSEGLVGALMHVMQKRSRAIHSSDEGEDQAGDEDEDDEWDD</Protein_Seq>
    <DNA_Seq>AGCCTCGCCAGAGAAGACAAGGGCAGAAAGCACCATGAGTGGGGGCCCAATGGGAGGAAGGCCCGGGGGCCGAGGAGCACCAGCGGTTCAGCAGAACATACCCTCCACCCTCCTCCAGGACCACGAGAACCAGCGACTCTTTGAGATGCTTGGACGAAAATGCTTGACGCTGGCCACTGCAGTTGTTCAGCTGTACCTGGCGCTGCCCCCTGGAGCTGAGCACTGGACCAAGGAGCATTGTGGGGCTGTGTGCTTCGTGAAGGATAACCCCCAGAAGTCCTACTTCATCCGCCTTTACGGCCTTCAGGCTGGTCGGCTGCTCTGGGAACAGGAGCTGTACTCACAGCTTGTCTACTCCACCCCCACCCCCTTCTTCCACACCTTCGCTGGAGATGACTGCCAAGCGGGGCTGAACTTTGCAGACGAGGACGAGGCCCAGGCCTTCCGGGCCCTCGTGCAGGAGAAGATACAAAAAAGGAATCAGAGGCAAAGTGGAGACAGACGCCAGCTACCCCCACCACCAACACCAGCCAATGAAGAGAGAAGAGGAGGGCTCCCACCCCTGCCCCTGCATCCAGGTGGAGACCAAGGAGGCCCTCCAGTGGGTCCGCTCTCCCTGGGGCTGGCGACAGTGGACATCCAGAACCCTGACATCACGAGTTCACGATACCGTGGGCTCCCAGCACCTGGACCTAGCCCAGCTGATAAGAAACGCTCAGGGAAGAAGAAGATCAGCAAAGCTGATATTGGTGCACCCAGTGGATTCAAGCATGTCAGCCACGTGGGGTGGGACCCCCAGAATGGATTTGACGTGAACAACCTCGACCCAGATCTGCGGAGTCTGTTCTCCAGGGCAGGAATCAGCGAGGCCCAGCTCACCGACGCCGAGACCTCTAAACTTATCTACGACTTCATTGAGGACCAGGGTGGGCTGGAGGCTGTGCGGCAGGAGATGAGGCGCCAGGAGCCACTTCCGCCGCCCCCACCGCCATCTCGAGGAGGGAACCAGCTCCCCCGGCCCCCTATTGTGGGGGGTAACAAGGGTCGTTCTGGTCCACTGCCCCCTGTACCTTTGGGGATTGCCCCACCCCCACCAACACCCCGGGGACCCCCACCCCCAGGCCGAGGGGGCCCTCCACCACCACCCCCTCCAGCTACTGGACGTTCTGGACCACTGCCCCCTCCACCCCCTGGAGCTGGTGGGCCACCCATGCCACCACCACCGCCACCACCGCCACCGCCGCCCAGCTCCGGGAATGGACCAGCCCCTCCCCCACTCCCTCCTGCTCTGGTGCCTGCCGGGGGCCTGGCCCCTGGTGGGGGTCGGGGAGCGCTTTTGGATCAAATCCGGCAGGGAATTCAGCTGAACAAGACCCCTGGGGCCCCAGAGAGCTCAGCGCTGCAGCCACCACCTCAGAGCTCAGAGGGACTGGTGGGGGCCCTGATGCACGTGATGCAGAAGAGAAGCAGAGCCATCCACTCCTCCGACGAAGGGGAGGACCAGGCTGGCGATGAAGATGAAGATGATGAATGGGATGACTGAGTGGCTGAGTTACTTGCTGCCCTGTGCTCCTCCCCGCAGGACATGGCTCCCCCTCCACCTGCTCTGTGCCCACCCTCCACTCTCCTCTTCCAGGGCCCCCAACCCCCCATTTCTTCCCCACCAACCCCTCCAATGCTGTTATCCCTGCCTGGTCCTCACACTCACCCAACAATCCCAAGGCCCTTTTTATACAAAAATTCTCAGTTCTCTTCACTCAAGGATTTTTAAAGAAAAATAAAAGAATTGTCTTTCTGTCTCTCTAT</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Thymus</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Spleen</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoskeleton</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>WAS</Gene_Name>
    <Gene_Alias>IMD2</Gene_Alias>
    <Gene_ID>7454</Gene_ID>
    <Genbank_ACCN>NM_000377</Genbank_ACCN>
    <Protein_ACCN>NP_000368</Protein_ACCN>
    <HGNC_ID>12731</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/7454</Gene_URL>
    <UCSC_ID>uc004dkm.4</UCSC_ID>
    <EMBL_ID>ENSG00000015285</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P42768</Uniprot_ID>
      <Gene_Name>WAS</Gene_Name>
      <EBI_ID>EBI-346375</EBI_ID>
      <PPI_EBI_URL>EBI-346375,EBI-346375</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P60953</Uniprot_ID>
      <Gene_Name>CDC42</Gene_Name>
      <EBI_ID>EBI-81752</EBI_ID>
      <PPI_EBI_URL>EBI-346375,EBI-81752</PPI_EBI_URL>
      <Experiment_Number>9</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>O43516</Uniprot_ID>
      <Gene_Name>WIPF1</Gene_Name>
      <EBI_ID>EBI-346356</EBI_ID>
      <PPI_EBI_URL>EBI-346375,EBI-346356</PPI_EBI_URL>
      <Experiment_Number>9</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P08631</Uniprot_ID>
      <Gene_Name>HCK</Gene_Name>
      <EBI_ID>EBI-346340</EBI_ID>
      <PPI_EBI_URL>EBI-346375,EBI-346340</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Severe Congenital Neutropenia X-Linked</Disease_Name>
      <Disease_Detail>Severe Congenital Neutropenia</Disease_Detail>
      <Disease_DB>SVR014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/severe_congenital_neutropenia_x_linked?search=WAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Severe Congenital Neutropenia</Disease_Name>
      <Disease_Detail>Severe Congenital Neutropenia</Disease_Detail>
      <Disease_DB>SVR003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/severe_congenital_neutropenia?search=WAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Wiskott-Aldrich Syndrome</Disease_Name>
      <Disease_Detail>Wiskott-Aldrich Syndrome</Disease_Detail>
      <Disease_DB>WSK001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/wiskott_aldrich_syndrome?search=WAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thrombotic Thrombocytopenic Purpura</Disease_Name>
      <Disease_Detail>Thrombotic Thrombocytopenic Purpura</Disease_Detail>
      <Disease_DB>THR005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thrombotic_thrombocytopenic_purpura?search=WAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thrombocytopenia</Disease_Name>
      <Disease_Detail>Thrombocytopenia</Disease_Detail>
      <Disease_DB>THR014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thrombocytopenia?search=WAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Neutropenia</Disease_Name>
      <Disease_Detail>Neutropenia</Disease_Detail>
      <Disease_DB>NTR004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/neutropenia?search=WAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thrombocytopenia, X-Linked, Intermittent</Disease_Name>
      <Disease_Detail>Thrombocytopenia</Disease_Detail>
      <Disease_DB>THR065</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thrombocytopenia_x_linked_intermittent?search=WAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Was-Related Disorders</Disease_Name>
      <Disease_Detail>Was-Related Disorders</Disease_Detail>
      <Disease_DB>WSR001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/was_related_disorders?search=WAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>X-Linked Thrombocytopenia</Disease_Name>
      <Disease_Detail>X-Linked Thrombocytopenia</Disease_Detail>
      <Disease_DB>XLN068</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/x_linked_thrombocytopenia?search=WAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thrombocytopenia 2</Disease_Name>
      <Disease_Detail>Thrombocytopenia</Disease_Detail>
      <Disease_DB>THR037</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thrombocytopenia_2?search=WAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Primary Immunodeficiency Disease</Disease_Name>
      <Disease_Detail>Primary Immunodeficiency Disease</Disease_Detail>
      <Disease_DB>PRM097</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/primary_immunodeficiency_disease?search=WAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Intussusception</Disease_Name>
      <Disease_Detail>Intussusception</Disease_Detail>
      <Disease_DB>INT051</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/intussusception?search=WAS#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Solution Structure of the GTPase Binding Domain of WASP in Complex with EspFU, an EHEC Effector</PDB_Title>
      <PDB_ID>2K42</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2K42</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural mechanism of WASP activation by the enterohaemorrhagic E. coli effector EspF(U).</PubMed_Title>
      <Author>Cheng HC, et al.</Author>
      <Journal>Nature. 2008 Aug 21;454(7207):1009-13.</Journal>
      <PubMed_ID>18650809</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SOLUTION STRUCTURE OF THE AUTOINHIBITED CONFORMATION OF WASP</PDB_Title>
      <PDB_ID>1EJ5</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1EJ5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein.</PubMed_Title>
      <Author>Kim AS, et al.</Author>
      <Journal>Nature. 2000 Mar 9;404(6774):151-8.</Journal>
      <PubMed_ID>10724160</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SOLUTION STRUCTURE OF CDC42 IN COMPLEX WITH THE GTPASE BINDING DOMAIN OF WASP</PDB_Title>
      <PDB_ID>1CEE</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1CEE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER</Ligand_Name>
      <PubMed_Title>Structure of Cdc42 in complex with the GTPase-binding domain of the 'Wiskott-Aldrich syndrome' protein.</PubMed_Title>
      <Author>Abdul-Manan N, et al.</Author>
      <Journal>Nature. 1999 May 27;399(6734):379-83.</Journal>
      <PubMed_ID>10360578</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Solution structure of the Wiskott-Aldrich Syndrome Protein (WASP) autoinhibited core domain complexed with (S)-wiskostatin, a small molecule inhibitor</PDB_Title>
      <PDB_ID>1T84</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1T84</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>(2S)-1-(3,6-DIBROMO-9H-CARBAZOL-9-YL)-3-(DIMETHYLAMINO)PROPAN- 2-OL</Ligand_Name>
      <PubMed_Title>Chemical inhibition of N-WASP by stabilization of a native autoinhibited conformation.</PubMed_Title>
      <Author>Peterson JR, et al.</Author>
      <Journal>Nat Struct Mol Biol. 2004 Aug;11(8):747-55.</Journal>
      <PubMed_ID>15235593</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Ternary complex of the WH2 domain of WASP with Actin-DNAse I</PDB_Title>
      <PDB_ID>2A3Z</PDB_ID>
      <Resolution>2.08</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2A3Z</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ADENOSINE-5'-TRIPHOSPHATE $FORMIC ACID $N-ACETYL-D-GLUCOSAMINE</Ligand_Name>
      <PubMed_Title>Actin-bound structures of Wiskott-Aldrich syndrome protein (WASP)-homology domain 2 and the implications for filament assembly.</PubMed_Title>
      <Author>Chereau D, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16644-9.</Journal>
      <PubMed_ID>16275905</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04520</Pathway_ID>
      <Pathway_Title>Adherens junction</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05231</Pathway_ID>
      <Pathway_Title>Choline metabolism in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04810</Pathway_ID>
      <Pathway_Title>Regulation of actin cytoskeleton</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cell motility</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05130</Pathway_ID>
      <Pathway_Title>Pathogenic Escherichia coli infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05100</Pathway_ID>
      <Pathway_Title>Bacterial invasion of epithelial cells</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05100</Pathway_ID>
      <Pathway_Title>Bacterial invasion of epithelial cells</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05132</Pathway_ID>
      <Pathway_Title>Salmonella infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05131</Pathway_ID>
      <Pathway_Title>Shigellosis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04666</Pathway_ID>
      <Pathway_Title>Fc gamma R-mediated phagocytosis</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04062</Pathway_ID>
      <Pathway_Title>Chemokine signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a/b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.fb.b.bb.dh.html</SCOP_URL>
    <CATH_Class>Mixed alpha-beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1cee</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>Buck M, et al. J.Mol.Biol. 2004,338(2):271-285.</Site_Reference>
      <Site_Type>A special quantitative two-state allosteric model</Site_Type>
      <PubMed_ID>15066431</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD03030001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03030002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03030003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03030004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03030005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>